IMR Press / EJGO / Volume 30 / Issue 6 / pii/2009162

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research

Endometrial stromal sarcoma: experience from a district hospital and literature review

Show Less
1 Department of Obstetrics and Gynaecology, The Queen Elizabeth Hospital, Norfolk (U.K.)
2 Department of Histopathology, Peterborough District Hospital, Cambridgeshire (U.K.)
3 Department of Obstetrics and Gynecology, Peterborough District Hospital, Cambridgeshire (U.K.)
Eur. J. Gynaecol. Oncol. 2009, 30(6), 664–667;
Published: 10 December 2009

 Purpose: Endometrial stromal sarcoma (ESS) is a rare malignancy of the uterus. Most cases are incidentally diagnosed on histological examination of hysterectomy specimens. Evidence on the management is accrued mainly from retrospective studies. This study aims to review the clinical experience of a district hospital in the diagnosis and management of this rare tumour over a 12-year period. Methods: Information on cases of ESS from 1995 to 2007 were retrieved from the histological database. All case files of identified patients were analysed and data extrapolated. A literature review was performed. Results: There were seven cases identified over this time period highlighting the rarity of ESS. Most cases were low-grade ESS and diagnosed retrospectively following surgery for presumed benign pathology. Cases with high-grade ESS and advanced stage low-grade ESS received adjuvant therapy. Conclusion: The primary treatment of ESS is surgery. The role of adjuvant therapy remains debatable, but generally involves radiotherapy, chemotherapy and hormonal therapy Optimal treatment protocols may be achieved by the conduct of randomised controlled clinical trials. 

Endometrial stromal sarcoma
Back to top